183 related articles for article (PubMed ID: 11548058)
1. Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives.
Haug BE; Skar ML; Svendsen JS
J Pept Sci; 2001 Aug; 7(8):425-32. PubMed ID: 11548058
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumour activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications.
Eliassen LT; Haug BE; Berge G; Rekdal O
J Pept Sci; 2003 Aug; 9(8):510-7. PubMed ID: 12952392
[TBL] [Abstract][Full Text] [Related]
3. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
Haug BE; Svendsen JS
J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
[TBL] [Abstract][Full Text] [Related]
4. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
Lejon T; Svendsen JS; Haug BE
J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
[TBL] [Abstract][Full Text] [Related]
5. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
Strøm MB; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
Haug BE; Andersen J; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic activity of pentadecapeptides modelled from amino acid descriptors.
Lejon T; Strøm MB; Svendsen JS
J Pept Sci; 2001 Feb; 7(2):74-81. PubMed ID: 11277499
[TBL] [Abstract][Full Text] [Related]
8. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of 15-residue lactoferricin derivatives.
Strøm MB; Rekdal O; Svendsen JS
J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
[TBL] [Abstract][Full Text] [Related]
10. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
[TBL] [Abstract][Full Text] [Related]
11. Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide.
Yang N; Lejon T; Rekdal O
J Pept Sci; 2003 May; 9(5):300-11. PubMed ID: 12803496
[TBL] [Abstract][Full Text] [Related]
12. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
[TBL] [Abstract][Full Text] [Related]
13. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
14. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
Lejon T; Stiberg T; Strøm MB; Svendsen JS
J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
[TBL] [Abstract][Full Text] [Related]
16. Stochastic-based descriptors studying biopolymers biological properties: extended MARCH-INSIDE methodology describing antibacterial activity of lactoferricin derivatives.
de Armas RR; Díaz HG; Molina R; Uriarte E
Biopolymers; 2005 Apr; 77(5):247-56. PubMed ID: 15682438
[TBL] [Abstract][Full Text] [Related]
17. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
Nguyen LT; Schibli DJ; Vogel HJ
J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
[TBL] [Abstract][Full Text] [Related]
18. Increased antibacterial activity of 15-residue murine lactoferricin derivatives.
Strøm MB; Rekdal O; Stensen W; Svendsen JS
J Pept Res; 2001 Feb; 57(2):127-39. PubMed ID: 11168896
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
[TBL] [Abstract][Full Text] [Related]
20. Homology similarity analysis of sequences of lactoferricin and its derivatives.
Nakai S; Chan JC; Li-Chan EC; Dou J; Ogawa M
J Agric Food Chem; 2003 Feb; 51(5):1215-23. PubMed ID: 12590458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
